Showing 31-40 of 348 results for "".
Diagnosing gMG: Navigating Current Tools and Approaches
https://practicalneurology.com/programs/cme/diagnosing-gmg-navigating-current-tools-and-approaches/32238/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Life-Threatening Events: Understanding and Preventing Myasthenic Crisis
https://practicalneurology.com/programs/cme/life-threatening-events-understanding-and-preventing-myasthenic-crisis/32237/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Autoantibodies in MG: Their Role in Diagnosis and Treatment
https://practicalneurology.com/programs/cme/autoantibodies-in-mg-their-role-in-diagnosis-and-treatment/32239/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Understanding Disease Progression: The Shift From Ocular to Generalized MG
https://practicalneurology.com/programs/cme/understanding-disease-progression-the-shift-from-ocular-to-generalized-mg/32236/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Optimizing FcRn Therapy: Addressing and Reducing Adverse Reactions
https://practicalneurology.com/programs/cme/optimizing-fcrn-therapy-addressing-and-reducing-adverse-reactions/32243/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Early Recognition + Earlier Intervention = Slowing the Progression in Mild Cognitive Impairment / Early Alzheimer’s
https://practicalneurology.com/programs/cme/early-recognition-earlier-intervention-slowing-the-progression-in-mild-cognitive-impairment-early-alzheimers/24279/Tune in to learn about early recognition and the latest on diagnosing and treating patients with mild cognitive impairment and early Alzheimer’s.The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action
https://practicalneurology.com/programs/cme/the-science-behind-fcrn-antagonists-a-deep-dive-into-their-mechanism-of-action/32241/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Balancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid
https://practicalneurology.com/programs/cme/balancing-risk-and-benefit-traditional-mg-treatments-and-medications-to-avoid/32240/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Headache Horizons: Key Updates in Headache and Migraine Care
https://practicalneurology.com/diseases-diagnoses/headache-pain/key-updates-in-headache-and-migraine-care/35529/From gepants to GLP-1 agonists, new therapies and a shift toward early intervention may redefine migraine care and improve quality of life for people with migraine.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31019/Optimizing Restless Legs Syndrome Treatment: Insights from Recent Meta-Analysis and Clinical ExperiencesA recent meta-analysis evaluating the side effects and wearing-off effects of four Restless Legs Syndrome (RLS) medications highlighted significant findings relevant to clinical practice. The stud